Autopsy report · NCT06230393

An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

“Sponsor decision to close this extension study due to reduction in sample size.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 1 year 6 months before it stopped.
• 17 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

New World Medical, Inc.

Sponsor type

Industry

Conditions

Open Angle Glaucoma; Intraocular Pressure

Interventions

STREAMLINE® SURGICAL SYSTEM

Participants

17

Sites

1

Countries

Costa Rica

Trials that died the same way

• FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia
  “Sponsor decision to terminate study prior to reaching full sample size.” (81% match in meaning)
• L-Menthol Injection as a Novel Technique During Colonoscopy
  “Sponsor/Investigator has decided to close out the study” (76% match in meaning)
• Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
  “Sponsor deprioritized the study and made the choice to close the study.” (74% match in meaning)
• A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
  “Sponsor Decision to close study” (74% match in meaning)
• A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer
  “Sponsor decision to early terminate the study” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.